伽瑪刀全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計伽瑪刀市場將從 2025 年的 5.1089 億美元成長到 2034 年的 8.1945 億美元，2026 年至 2034 年的複合年成長率為 5.39%。

由於對腦部疾病非侵入性治療方法的需求不斷成長，全球伽瑪刀市場正經歷顯著成長。伽瑪刀技術被廣泛用於高精度治療腦腫瘤、動靜脈畸形和其他神經系統疾病。神經系統疾病發生率的上升以及人們對微創手術日益成長的偏好正在推動市場擴張。此外，醫學影像和放射治療技術的進步也正在改善治療效果。

主要成長要素包括立體定位放射放射線手術的日益普及和先進醫療設施的建設。伽瑪刀系統因其恢復時間更短、風險低於傳統手術而備受青睞。醫療基礎設施投資的增加以及對改善患者預後的日益重視，進一步推動了市場成長。此外，患者和醫療專業人員認知度的提高也促進了伽瑪刀系統的廣泛應用。

伽瑪刀市場預計未來將穩定成長，這主要得益於技術的不斷進步和臨床應用的持續拓展。人工智慧（AI）與診斷影像技術的融合將提升治療的精準度與效率。在新興市場，由於醫療保健投資的增加和先進醫療服務的普及，伽瑪刀有望發揮重要作用。此外，持續的研發和創新將確保伽瑪刀系統的效能不斷提升。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球伽瑪刀市場：依適應症分類

• 市場分析、洞察與預測
• 血管疾病
• 腦轉移
• 眼科疾病
• 功能障礙
• 動靜脈畸形（AVM）
• 三叉神經痛
• 運動障礙
• 癌症
• 其他

第5章：全球伽瑪刀市場：依解剖部位分類

• 市場分析、洞察與預測
• 頭
• 脖子
• 其他

第6章：全球伽瑪刀市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 門診部

第7章：全球伽瑪刀市場：依範圍分類

• 市場分析、洞察與預測
• 高階伽瑪刀
• 中型伽瑪刀
• 原始伽瑪刀

第8章 全球伽瑪刀市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Elekta
  • Varian
  • Accuray Incorporated
  • Vision RT Ltd
  • MASEP Medical Science & Technology Development Co
  • Nordion Inc
  • Brainlab AG
  • CQ Medical
  • Ono Sokki Co. Ltd
  • Panacea Medical Technologies Pvt. Ltd
  • Akesis Inc
  • Fortis Healthcare
  • Corewell Health

The Gamma Knife Market size is expected to reach USD 819.45 Million in 2034 from USD 510.89 Million (2025) growing at a CAGR of 5.39% during 2026-2034.

The global gamma knife market is witnessing notable growth due to the increasing demand for non-invasive treatment options for brain disorders. Gamma knife technology is widely used for treating brain tumors, arteriovenous malformations, and other neurological conditions with high precision. The rising incidence of neurological disorders and the growing preference for minimally invasive procedures are driving market expansion. Additionally, advancements in medical imaging and radiation therapy technologies are enhancing treatment outcomes.

Key growth drivers include the increasing adoption of stereotactic radiosurgery and the growing availability of advanced healthcare facilities. Gamma knife systems offer reduced recovery time and lower risk compared to traditional surgical procedures, making them highly preferred. The rising investments in healthcare infrastructure and the growing focus on improving patient outcomes are further supporting market growth. Additionally, increasing awareness among patients and healthcare providers is contributing to wider adoption.

Looking ahead, the gamma knife market is expected to grow steadily with continuous technological advancements and expanding clinical applications. The integration of artificial intelligence and imaging technologies will improve treatment precision and efficiency. Emerging markets are likely to play a key role due to increasing healthcare investments and improving access to advanced medical treatments. Furthermore, ongoing research and innovation will continue to enhance the capabilities of gamma knife systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Disease Indications

• Vascular Disorders
• Brain Metastasis
• Ocular Diseases
• Functional Disorders
• Arteriovenous Malformation (AVM)
• Trigeminal Neuralgia
• Movement Disorders
• Cancer
• Others

By Anatomy

• Head
• Neck
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Service Centers

By Range

• High-End Gamma Knife
• Medium Gamma Knife
• Low Gamma Knife

COMPANIES PROFILED

• Elekta, Varian, Accuray Incorporated, Vision RT Ltd, MASEP Medical Science Technology Development Co, Nordion Inc, Brainlab AG, CQ Medical, Ono Sokki Co Ltd, Panacea Medical Technologies Pvt Ltd, Akesis Inc, Fortis Healthcare, Corewell Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GAMMA KNIFE MARKET: BY DISEASE INDICATIONS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease Indications
• 4.2. Vascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Brain Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ocular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Functional Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Arteriovenous Malformation (AVM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Trigeminal Neuralgia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Movement Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GAMMA KNIFE MARKET: BY ANATOMY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Anatomy
• 5.2. Head Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neck Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GAMMA KNIFE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Service Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GAMMA KNIFE MARKET: BY RANGE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Range
• 7.2. High-End Gamma Knife Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medium Gamma Knife Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Low Gamma Knife Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GAMMA KNIFE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Disease Indications
  • 8.2.2 By Anatomy
  • 8.2.3 By End User
  • 8.2.4 By Range
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Disease Indications
  • 8.3.2 By Anatomy
  • 8.3.3 By End User
  • 8.3.4 By Range
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Disease Indications
  • 8.4.2 By Anatomy
  • 8.4.3 By End User
  • 8.4.4 By Range
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Disease Indications
  • 8.5.2 By Anatomy
  • 8.5.3 By End User
  • 8.5.4 By Range
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Disease Indications
  • 8.6.2 By Anatomy
  • 8.6.3 By End User
  • 8.6.4 By Range
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GAMMA KNIFE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Elekta
  • 10.2.2 Varian
  • 10.2.3 Accuray Incorporated
  • 10.2.4 Vision RT Ltd
  • 10.2.5 MASEP Medical Science & Technology Development Co
  • 10.2.6 Nordion Inc
  • 10.2.7 Brainlab AG
  • 10.2.8 CQ Medical
  • 10.2.9 Ono Sokki Co. Ltd
  • 10.2.10 Panacea Medical Technologies Pvt. Ltd
  • 10.2.11 Akesis Inc
  • 10.2.12 Fortis Healthcare
  • 10.2.13 Corewell Health